A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis

Phase 3TerminatedNCT00333996

Allergan5 enrolled

Overview

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious anterior uveitis.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Anterior Uveitis

Interventions

DexamethasoneDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years or older with a diagnosis of non-infectious anterior uveitis in at least one eye Exclusion Criteria: * Uncontrolled systemic disease * Any active ocular infections

Locations (1)

Unnamed facility

Dallas, Texas, United States

Outcomes

Primary Outcomes

Anterior Chamber Cell

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.